MyFinsight
Home
Blog
About
Cash and cash
equivalents
$171,593K
Prepaid expenses and
other current assets
$7,413K
(368.58%↑ Y/Y)
Total current assets
$179,006K
(16.07%↑ Y/Y)
Other assets
$1,498K
(15.23%↑ Y/Y)
Operating lease
right-of-use assets
$1,271K
(-20.91%↓ Y/Y)
Property and equipment,
net
$876K
(353.89%↑ Y/Y)
Restricted cash
$107K
(0.94%↑ Y/Y)
Total assets
$182,758K
(16.09%↑ Y/Y)
Total liabilities and
shareholders equity
$182,758K
(16.09%↑ Y/Y)
Total shareholders'
equity
$163,255K
(17.24%↑ Y/Y)
Total liabilities
$19,503K
(7.28%↑ Y/Y)
Accumulated deficit
-$219,929K
(-301.29%↓ Y/Y)
Additional paid-in capital
$379,156K
(99.51%↑ Y/Y)
Total current
liabilities
$18,537K
(10.70%↑ Y/Y)
Operating lease
liability, noncurrent
$966K
(-32.59%↓ Y/Y)
Non-voting convertible
preferred shares, 0.001...
$4,000K
Ordinary shares, 0.001
par value...
$28K
(100.00%↑ Y/Y)
Accrued expenses and
other current...
$7,407K
Deposit liability
$5,000K
Deferred revenue
$3,117K
Accounts
payable-Nonrelated Party
$2,542K
(54.25%↑ Y/Y)
Operating lease
liability, current
$471K
(123.22%↑ Y/Y)
Back
Back
Balance Sheet
CRESCENT BIOPHARMA, INC. (CBIO)
CRESCENT BIOPHARMA, INC. (CBIO)
source: myfinsight.com